glp 1 receptor agonists incretin mimetics A Brief Review of Intended for the Management of Diabetes and Associated Comorbidities[v1] Alimentary Pharmacology & Therapeutics |

Each system is evaluated with explicit attention to the evidence supporting biological relevance, the reasons for historical underexploration, and the translational questions that must be addressed to enable renewed development

PLoS ONE 18(8 August):120 (2016) Liraglutide and cardiovascular outcomes in type 2 diabetes

The combination of exenatide and antiemetic agents had good safety and tolerability, with no adverse effects on neurological function and prognosis

This improvement promotes ECM remodeling and helps prevent the pathological fibrosis associated with various eye diseases (Shan et al., 2023)

Kuznetsova, A., Brockhoff, P